Person-centred language for describing stratified approaches to TB treatment

Affiliations

¹ Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
² UCSF Institute for Global Health Sciences (IGHS), University of California, San Francisco, San Francisco, CA, USA.
³ UCSF Center for Tuberculosis, University of California, San Francisco, San Francisco, CA, USA.
⁴ Treatment Action Group, New York, NY, USA.
⁵ Access to Rights and Knowledge Foundation, Kohima, India.
⁶ Universidad Autónoma de Durango, Mexicali Campus, Mexico.
⁷ Department of Political Science, Stellenbosch University, Cape Town, South Africa.
⁸ Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.

M Nash et al. IJTLD Open. 2025.

. 2025 Jan 1;2(1):56-58.

doi: 10.5588/ijtldopen.24.0593. eCollection 2025 Jan.

¹ Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
² UCSF Institute for Global Health Sciences (IGHS), University of California, San Francisco, San Francisco, CA, USA.
³ UCSF Center for Tuberculosis, University of California, San Francisco, San Francisco, CA, USA.
⁴ Treatment Action Group, New York, NY, USA.
⁵ Access to Rights and Knowledge Foundation, Kohima, India.
⁶ Universidad Autónoma de Durango, Mexicali Campus, Mexico.
⁷ Department of Political Science, Stellenbosch University, Cape Town, South Africa.
⁸ Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.

No abstract available

Keywords: stigma; stigmatizing language; tuberculosis.

Conflict of interest statement

Conflicts of interest: none declared.

1. Imperial MZ, et al. . A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nature Medicine 2018;24(11):1708–1715. - PMC - PubMed
1. Imperial MZ, et al. . Precision-enhancing risk stratification tools for selecting optimal treatment durations in tuberculosis clinical trials. Am J Respir Crit Care Med. 2021;204(9):1086–1096. - PMC - PubMed
1. Turkova A, et al. . Shorter treatment for nonsevere tuberculosis in African and Indian children. N Engl J Med. 2022;386(10):911–922. - PMC - PubMed
1. Makone A, et al. . One size does not fit all: community views on choices for TB treatment and prevention. Public Health Action. 2023;13(3):67–69. - PMC - PubMed
1. Umana B, et al. . Transforming the language used in tuberculosis care. PLoS Glob Public Health. 2023;3(3):e0001657. - PMC - PubMed